• Novartis’ AveXis doubles down with $115M manufacturing investment fiercepharma
    February 24, 2019
    As an FDA action date quickly approaches for a gene therapy that Novartis snatched up last year, the biotech that is developing the treatment says it needs to more than double the size of its new manufacturing operations. AveXis now plans to have 400 empl
PharmaSources Customer Service